Evolution of multiple omics approaches to define pathophysiology of pediatric acute respiratory distress syndrome

Area of Science:

• Critical care medicine
• Pediatric pulmonology
• Molecular biology

Background:

• Pediatric acute respiratory distress syndrome (PARDS) is a severe, life-threatening condition in critically ill children lacking specific treatments.
• Understanding the complex pathobiology involving lung epithelial injury, vascular endothelial activation, and systemic immune responses is crucial for developing targeted therapies.
• Current research faces limitations due to a scarcity of pediatric-specific omics data and multi-tissue analyses.

Purpose of the Study:

• To synthesize current literature on PARDS molecular mechanisms.
• To analyze publicly available genomic data for candidate gene associations with PARDS phenotypes across various tissues and cell types.
• To integrate findings from recent single-cell RNA sequencing (scRNA-seq) studies.

Main Methods:

• Literature synthesis on PARDS molecular mechanisms.
• Bioinformatic analysis of public genomic databases to identify candidate genes linked to PARDS phenotypes.
• Integration of scRNA-seq data to examine cellular and tissue-level pathobiology.

Main Results:

• Identification of candidate genes associated with PARDS phenotypes across multiple tissues and cell types.
• Integration of multi-omics data, including scRNA-seq, provides a comprehensive view of PARDS pathobiology.
• Highlighting the limitations of current omics studies in pediatric populations.

Conclusions:

• Novel profiling techniques like scRNA-seq are essential for unbiased, comprehensive evaluation of PARDS pathophysiological mechanisms.
• Employing advanced methods like scRNA-seq is critical for uncovering molecular targets for novel pharmacotherapies.
• Further research utilizing scRNA-seq is recommended to advance the development of targeted treatments for PARDS.